Chronic disease · Crohn’s & colitis · Conversation prep
This tool prepares you to have the escalation conversation with your gastroenterologist or GP as an informed equal. It does not tell you what to escalate to, or whether to escalate at all — that is a decision you make together with your specialist.
Just to check — is the bleeding happening right now, or is it something to discuss with your gastro?
Severe or worsening belly pain, heavy bleeding, or a fever while you’re on immune-suppressing medicine needs to be checked straight away — these can move fast in Crohn’s and colitis. Call 000 or go to your nearest emergency department now.
This tool helps you prepare — it can’t tell if something is serious. If you’re worried it might be urgent, call 000 or your GP now.
In your words
The one thing to know
The shape of the decision
An ordered list of the four general rungs of IBD treatment, from gentlest to strongest: first, 5-ASA aminosalicylates, central in ulcerative colitis and of limited role in Crohn’s; second, corticosteroids, used short-term only to settle a flare and not as a maintenance drug; third, immunomodulators such as azathioprine, mercaptopurine and methotrexate; fourth, biologics and advanced therapies including anti-TNF, ustekinumab, vedolizumab and JAK inhibitors, for which PBS access criteria apply. This is a general order your gastroenterologist tailors — it is not a recommendation of what you should do.
Rungs and their contents come from Crohn’s & Colitis Australia — Medication for IBD and Biologics for IBD. This is a general map, not a path you should follow — your gastro places you on it and decides the order with you.
The honest bit
The other side of the same numbers. Treating early isn’t free. Stepping up means stronger medicines with real trade-offs — immunomodulators and biologics raise infection risk and need ongoing blood monitoring, and not everyone needs the aggressive path. The PROFILE result was for newly-diagnosed Crohn’s; it doesn’t automatically apply to long-standing disease or to ulcerative colitis. And in Australia, which biologic you can even access is gated by PBS rules, not just by what’s best on paper — most biologics require you to have already failed or not tolerated steroids plus an immunomodulator first. (CCA — Biologics for IBD; PBS access context, AURORA/ANZIBD.)
You’ll get a clean printable: the step-up vs top-down framing, the treatment ladder, the honest trade-offs, and the questions to ask your gastro — on one page you can hand over.
That email looks off — mind checking it?
·
This is the general map. The full Crohn’s & Colitis decision kit walks your exact situation — the real remission and risk numbers for each option, the PBS access path, and a question worksheet you fill in with your gastro. → See the kit
Weighing the escalation decision itself? Try the questions-to-ask generator. Want the real “X in 100” numbers for a specific option? Try the risk-numbers tool. Prepping for the gastro appointment? Try consult prep.